3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
5
Carcinoma, Hepatocellular
5
Breast Neoplasms
4
Neoplasms
3
Lung Neoplasms
3
Glioblastoma
3
Squamous Cell Carcinoma of Head and Neck
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Mouth Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Waldenstrom Macroglobulinemia
1
Thrombosis
1
Radiation Injuries
1
Prostatic Neoplasms, Castration-Resistant
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Meningioma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Radiotherapy
24
Radiotherapy, Intensity-Modulated
8
Radiosurgery
6
Amifostine
5
Low-Level Light Therapy
4
Donepezil
4
Cisplatin
4
Carboplatin
4
Surveys and Questionnaires
3
Radiation
3
Proton Therapy
3
Paclitaxel
3
Neuropsychological Tests
3
Heavy Ion Radiotherapy
3
Etoposide
3
Chemotherapy, Adjuvant
3
Chemoradiotherapy
3
Brachytherapy
3
Bevacizumab
3
Surgical Procedures, Operative
2
Radiation Dose Hypofractionation
2
Patient Reported Outcome Measures
2
Mental Status and Dementia Tests
2
Esophagectomy
2
Androgen Antagonists
2
Adrenal Cortex Hormones
2
sodium propionate
1
sargramostim
1
olaparib
1
endostar protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Radiation Injuries
×
Photons
×
Clear all
NCT05548504
2022-09-21
HERAN2
Odense University Hospital
Phase 2
Not yet recruiting
182 enrolled